Inovio Pharmaceuticals
INO
INO
184 hedge funds and large institutions have $196M invested in Inovio Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 67 increasing their positions, 36 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
34% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 32
41% less capital invested
Capital invested by funds: $330M → $196M (-$134M)
Holders
184
Holding in Top 10
–
Calls
$2.14M
Puts
$2.82M
Top Buyers
| 1 | +$15.4M | |
| 2 | +$4.95M | |
| 3 | +$3.88M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.67M |
| 5 |
BlackRock
New York
|
+$3.25M |
Top Sellers
| 1 | -$1.79M | |
| 2 | -$1.11M | |
| 3 | -$750K | |
| 4 |
Group One Trading
Chicago,
Illinois
|
-$675K |
| 5 |
Capital Fund Management (CFM)
Paris,
France
|
-$380K |